These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 24636973

  • 1. Oral contraceptive use and risk of cancer--response.
    Gierisch JM, Myers ER.
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):677-8. PubMed ID: 24636973
    [No Abstract] [Full Text] [Related]

  • 2. Oral contraceptive use and risk of cancer--letter.
    Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):676. PubMed ID: 24636972
    [No Abstract] [Full Text] [Related]

  • 3. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM, Coeytaux RR, Urrutia RP, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, McBroom AJ, Hasselblad V, Sanders GD, Myers ER.
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
    [Abstract] [Full Text] [Related]

  • 4. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F.
    PLoS Med; 2012 Nov; 9(3):e1001182. PubMed ID: 22412354
    [Abstract] [Full Text] [Related]

  • 5. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
    Schlesselman JJ.
    Obstet Gynecol; 1995 May; 85(5 Pt 1):793-801. PubMed ID: 7724116
    [Abstract] [Full Text] [Related]

  • 6. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I, Swerdlow AJ.
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [Abstract] [Full Text] [Related]

  • 7. [Use of oral contraceptives and increased risk of cervical cancer].
    Schmeink CE, Lenselink CH, Bekkers RL.
    Ned Tijdschr Geneeskd; 2008 Aug 02; 152(31):1717-8. PubMed ID: 18727601
    [Abstract] [Full Text] [Related]

  • 8. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
    Jordan SJ, Wilson LF, Nagle CM, Green AC, Olsen CM, Bain CJ, Pandeya N, Whiteman DC, Webb PM.
    Aust N Z J Public Health; 2015 Oct 02; 39(5):441-5. PubMed ID: 26437729
    [Abstract] [Full Text] [Related]

  • 9. Hormonal contraception and chemoprevention of female cancers.
    Pike MC, Spicer DV.
    Endocr Relat Cancer; 2000 Jun 02; 7(2):73-83. PubMed ID: 10903525
    [Abstract] [Full Text] [Related]

  • 10. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T, Johansson T, Höglund J, Ek WE, Johansson Å.
    Cancer Res; 2021 Feb 15; 81(4):1153-1162. PubMed ID: 33334812
    [Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy and the risk of reproductive cancers.
    Swan SH.
    J Psychosom Obstet Gynaecol; 1997 Jun 15; 18(2):165-74. PubMed ID: 9219113
    [No Abstract] [Full Text] [Related]

  • 12. [Recent trends in multiple primary cancers associated with gynecological malignancy].
    Sakaguchi I, Katabuchi H, Okamura H.
    Nihon Rinsho; 2004 Oct 15; 62 Suppl 10():607-10. PubMed ID: 15535317
    [No Abstract] [Full Text] [Related]

  • 13. [Use of oral contraceptives and risk of cancer, a cohort study].
    Kumle M, Alsaker E, Lund E.
    Tidsskr Nor Laegeforen; 2003 Jun 12; 123(12):1653-6. PubMed ID: 12821980
    [Abstract] [Full Text] [Related]

  • 14. Geographic peculiarities of endometrial and cervical cancer incidence in five continents (review).
    Tkeshelashvili VT, Bokhman JV, Kuznetzov VV, Maximov SJ, Chkuaseli GT.
    Eur J Gynaecol Oncol; 1993 Jun 12; 14(2):89-94. PubMed ID: 8500502
    [Abstract] [Full Text] [Related]

  • 15. [Oral contraceptives and cancer].
    Thomas DB.
    Adv Contracept; 1993 Mar 12; 9 Suppl 1():31-48. PubMed ID: 8512029
    [No Abstract] [Full Text] [Related]

  • 16. Oral contraceptives and reproductive organ cancer risk.
    Smith EM, Corder MP.
    J Iowa Med Soc; 1982 Nov 12; 72(11):456-7. PubMed ID: 7175242
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
    Jalil NA, Zin AA, Othman NH.
    Asian Pac J Cancer Prev; 2015 Nov 12; 16(16):7267-70. PubMed ID: 26514522
    [Abstract] [Full Text] [Related]

  • 18. The long-term impact of oral contraceptives on ovarian and endometrial carcinogenesis.
    La Vecchia C.
    Eur J Cancer Prev; 2000 Jun 12; 9(3):137-8. PubMed ID: 10954252
    [No Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and cancer.
    Edgren RA.
    Int J Fertil; 1991 Jun 12; 36 Suppl 3():37-50. PubMed ID: 1687403
    [Abstract] [Full Text] [Related]

  • 20. Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer.
    Modesitt SC, Gambrell AC, Cottrill HM, Hays LR, Walker R, Shelton BJ, Jordan CE, Ferguson JE.
    Obstet Gynecol; 2006 Jun 12; 107(6):1330-6. PubMed ID: 16738160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.